Cefpodoxime & Potassium Clavulanate Tablets – Tilpod CV Tablets

Tilpod CV Tablets
Composition:- Cefpodoxime 200 mg + Clavulanic Acid 125 mg

Tilpod CV Tablets – This combination of Cefpodoxime 200 mg and Potassium Clavulanate 125 mg is designed for the management of moderate to severe bacterial infections. Cefpodoxime works by blocking bacterial cell wall synthesis, while Clavulanic Acid inhibits β-lactamase enzymes that cause resistance. Together, they broaden antibacterial coverage, especially against β-lactamase–producing organisms, ensuring more reliable treatment results.

Key Points of Cefpodoxime & Potassium Clavulanate Tablets – Tilpod CV Tablets
• Broad Antimicrobial Coverage with Resistance Protection: Cefpodoxime, a third-generation cephalosporin, acts on both gram-positive and gram-negative bacteria. Clavulanic acid shields the antibiotic from β-lactamase–mediated resistance, restoring its full activity.
• Strong Effectiveness in Respiratory & Urinary Infections: Provides excellent therapeutic action in ENT infections, lower respiratory tract illnesses, and urinary tract infections, including cases with partial resistance.
• Better Outcomes in Complicated or Recurrent Cases: The dual-action approach enhances bacterial clearance, reduces recurrence, and minimises treatment failures in chronic or resistant infections.

Can be Prescribed by:
• General Physicians
• Pediatricians
• ENT Specialists
• Pulmonologists
• Infectious Disease Specialists
• Healthcare practitioner

Disclaimer: To be used under medical supervision only and not intended for general public promotion. This content is meant for registered healthcare professionals only.